ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CD Bioparticles Announces Versatile Basic Agarose Particles for Efficient Biomolecule Separation

CD Bioparticles Announces Versatile Basic Agarose Particles for Efficient Biomolecule Separation
CD Bioparticles announces new line of Basic Agarose Particles for efficient biomolecule separation.

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces the availability of its new line of Basic Agarose Particles for efficient biomolecule separation. These versatile, unmodified agarose microspheres offer researchers a powerful tool for various applications, including protein purification, negative controls in experiments, and the foundation for further functionalization.

Basic agarose particles are non-preactivated agarose microspheres. The unmodified and unactivated particles are useful for removing proteins and other samples containing components that bind non-specifically to agarose, thereby reducing background signal and non-specific binding in IP and Co-IP experiments. They can also be used as negative controls to distinguish between specific and non-specific interactions.

Agarose derivatives are ideal supports for affinity chromatography, ion exchange chromatography and hydrophobic interaction chromatography. Cross-linked agarose particles are high-density agarose particles with more cross-linked polysaccharide chains. As a result, they have significantly improved chemical stability and physical properties and can withstand higher pressures. These particles provide researchers with a powerful toolkit to enhance their experiments and accelerate scientific discovery.

Committed to advancing bio-research with innovative solutions, CD Bioparticles offers a variety of Basic Agarose Particles for efficient separations, including 1) Control Agarose Particles, 4% cross-linked, unmodified for use as negative controls or to remove proteins and other non-specifically bound sample components in IP and Co-IP assays, and 2) High Flow Agarose Particles, with a maximum linear velocity of up to 1000 cm/h at 15 cm bed height and a maximum working pressure of up to 300 kPa, suitable for high pressure separations such as FPLC and HPLC.

Non-crosslinked and highly crosslinked basic agarose particles with different particle sizes and agarose contents are also available upon request. In addition, CD Bioparticles offers autoclavable basic agarose particles that can withstand temperatures up to 120°C. With a broad fractionation range from 10 kDa to 4000 kDa, these particles exhibit low non-specific adsorption due to removing charged impurities from refined agarose. Their particle size spans 45 µm to 200 µm, ensuring high recovery rates and multiple reuses.

These versatile particles, meticulously crafted by CD Bioparticles' experienced team, empower researchers across diverse fields with precision and reliability. They can serve as essential tools for pre-clearing protein samples, reducing background signal and nonspecific binding in immunoprecipitation (IP) and co-immunoprecipitation (Co-IP) assays. Additionally, these particles act as negative controls, distinguishing specific from nonspecific interactions. When further functionalized, agarose particles become supports for affinity chromatography, ion exchange chromatography and hydrophobic interaction chromatography. Researchers can tailor the functionality of agarose beads to suit specific applications.

CD Bioparticles offers versatile Basic Agarose Particles for efficient isolation and purification of biological macromolecules. For more information and to explore the full range of new products, please visit CD Bioparticles at https://www.cd-bioparticles.com/products/basic-agarose-particles-1064.html.

About CD Bioparticles

CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.

Media Contact
Company Name: CD Bioparticles
Contact Person: Richard J. Gray
Email: Send Email
State: New York
Country: United States
Website: https://www.cd-bioparticles.com/


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.